FHL1 variants in HCM cohorts

The table below lists the 14 rare (MAF<0.0001 in ExAC) protein-altering FHL1 variants identified in a cohort of 1535 HCM patients. When this rare variant frequency of 0.00912 is compared with a background population rate of 0.00123, there is a statistically significant case excess of 0.00789 (p<0.0001), which suggests that approximately 12 of these variants may be pathogenic.

Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      OMGL

No. Variant (CDS) Variant (Protein) Variant Type Cases (1535)OMGL class ExAC frequency
1. c.113A>G p.N38Smissense 4VUS (4)0.000000
2. c.211T>A p.C71Smissense 1VUS (1)0.000000
3. c.331G>T p.G111Xnonsense 1Pathogenic (1)0.000000
4. c.556T>C p.F186Lmissense 1VUS (1)0.000011
5. c.221C>G p.P74Rmissense 1VUS (1)0.000000
6. c.343G>T p.V115Lmissense 1VUS (1)0.000022
7. c.142G>A p.G48Smissense 1VUS (1)0.000000
8. c.523A>C p.T175Pmissense 1VUS (1)0.000000
9. c.661T>C p.C221Rmissense 1VUS (1)0.000011
10. c.280A>G p.T94Amissense 1VUS (1)0.000000
11. c.395G>T p.C132Fmissense 1VUS (1)0.000000


1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015 Nov;17(11):880-8.